1. From the Bayer-chair Department of Molecular Immunology and Allergy, Graduate School of Medicine, Kyoto University, Kyoto, Japan; the Division of Pediatric Hemato-Oncology, Hadassah Medical Center, Jerusalem, Israel; the Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and the Department of Pediatrics, Meyer Children Hospital, Rambam Medical Center and the B. Rappaport School of Medicine, Technion, Haifa, Israel.